Literature DB >> 6420835

Dopamine/L-dopa ratio in cerebrospinal fluid of parkinsonian patients treated with L-dopa + benserazide.

M Fekete, M Tárczy, K Bihari, G Katona.   

Abstract

The CSF dopamine/L-dopa ratio was examined in 14 parkinsonian and six control patients. In parkinsonian patients the dopamine/L-dopa ratio showed significant correlation with the severity of the disease, as characterized by Yahr's scale. These data suggest some correlation between the dopamine synthesizing capacity and the degree of disability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420835     DOI: 10.1007/bf00426388

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  On the presence of 3-hydroxytyramine in brain.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON; B WALDECK
Journal:  Science       Date:  1958-02-28       Impact factor: 47.728

2.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

4.  Simultaneous radioenzymatic assay of catecholamines and dihydroxy-phenylacetic acid /DOPAC/; comparison of the effects of drugs on the tuberoinfundibular and striatal dopamine metabolism and on plasma prolactin level.

Authors:  M I Fekete; B Kanyicska; J P Herman
Journal:  Life Sci       Date:  1978-10-16       Impact factor: 5.037

5.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

6.  Catechol-O-methyltransferase. II. A new class of inhibitors of catechol-o-methyltransferase; 3,5-dihydroxy-4-methoxybenzoic acid and related compounds.

Authors:  B Nikodejevic; S Senoh; J W Daly; C R Creveling
Journal:  J Pharmacol Exp Ther       Date:  1970-07       Impact factor: 4.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.